GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Metropolis Healthcare Ltd

Metropolis Healthcare Board Meeting on Nov 3 to Consider Dividend, Q2 FY27 Results

DIVIDEND ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 28 Oct 2026, 09:08 PM IST  ·  BSE ID: 0f492bf7-94f0-487a-815f-a9b39e249499
View Original BSE Filing (PDF)
💡
In Simple Terms
Metropolis Healthcare's directors will meet to approve financial results and decide on paying an interim dividend.
🤖 AI Summary
  • Metropolis Healthcare board meeting scheduled for November 3, 2026.
  • Review of unaudited standalone and consolidated financial results for H1 FY27.
  • Consideration of declaration of interim dividend for FY2026-27.
  • Trading window closed from October 1, 2026, to November 5, 2026.
🏢 How This Affects the Company
💰
Financial Impact
Declaration of an interim dividend will reduce the company's cash reserves.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time.
👤
Who Is Affected
All shareholders are affected by the potential declaration of an interim dividend.
🔍
Management Signal
The board's consideration of an interim dividend signals an intent to distribute profits to shareholders.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
November 3, 2026: Board meeting outcome for results and dividend.
Company's Q2 FY27 financial results disclosure.
Announcement of interim dividend, if declared.
LOW RISK Routine board meeting for financial results and dividend consideration.
💡 Investor Takeaway
Metropolis Healthcare's board will review Q2 FY27 results and consider an interim dividend for FY2026-27 on November 3, 2026.
📅 Company Track Record
In May 2026, Metropolis Healthcare approved a second interim dividend of Rs. 10 per share for FY2025-26.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is the Metropolis Healthcare board meeting scheduled?
The Metropolis Healthcare board meeting is scheduled for Tuesday, November 03, 2026.
What will be discussed at the Metropolis Healthcare board meeting?
The board will consider unaudited financial results for the quarter and half year ended September 30, 2026, and an interim dividend for FY2026-27.
When is the trading window closed for Metropolis Healthcare?
The trading window for dealing in Metropolis Healthcare securities is closed from October 01, 2026, to November 05, 2026, inclusive.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.